Trading Ideas Biogen Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 03:27:46 2024-04-29 pm EDT			5-day change	1st Jan Change
215.4 ^USD	+3.10%		+10.81%	-16.88%

Apr. 26	Guggenheim Adjusts Price Target on Biogen to $255 From $275	MT
Apr. 25	Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA	CI

BIOGEN INC. :The underlying trend is in force again	20-08-26
BIOGEN INC. :Buying pressure	20-08-07
BIOGEN INC. :Close to an important medium term support level	18-02-26
BIOGEN INC. :Back on a stimulating support	14-11-18
BIOGEN INC. :The bullish trend is not over	13-07-29

No results for this search